マブチ ミユキ
馬渕 美雪 所属 兵庫医科大学 薬学部 医療薬学科 職種 助教 |
|
言語種別 | 日本語 |
発行・発表の年月 | 2001/05 |
形態種別 | 学術雑誌 |
査読 | 査読あり |
標題 | Induction of choleresis by immunosuppressant FK506 through stimulation of insulin-like growth factor-I production in the liver of rats. |
執筆形態 | 共著 |
掲載誌名 | European journal of pharmacology |
掲載区分 | 国外 |
巻・号・頁 | 419(1),99-105頁 |
著者・共著者 | Kawamura I, Takeshita S, Fushimi M, Mabuchi M, Seki J, Goto T |
概要 | FK506 (Tacrolimus) is an effective immunosuppressant currently used worldwide in organ transplantation. Based on our recent findings that insulin-like growth factor-I (IGF-I) is important for the stimulation of choleresis in vivo, in this study we investigated the effect of FK506 on bile flow and the plasma and hepatic levels of IGF-I in rats. Intravenous treatment of rats with FK506 resulted in a significant increase in bile flow, whereas cyclosporin A induced a significant decrease. A significant increase in plasma levels of IGF-I was observed in rats 30 min after a single intravenous administration of FK506. Oral treatment of rats with FK506 for 1 week also resulted in an increase in both plasma and hepatic levels of IGF-I. Overall, this study showed that FK506 treatment increased bile flow and also induced an increase in the plasma and hepatic levels of IGF-I in rats, suggesting that a stimulation of hepatic IGF-I production by FK506 may contribute to its choleretic profile. |
DOI | 10.1016/s0014-2999(01)00961-x |
ISSN | 0014-2999 |
PMID | 11348636 |